-
EP4070815
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4070815
| EP4070815 - HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 14.04.2023 Database last updated on 19.10.2024 | |
| Former | The application has been published Status updated on 09.09.2022 | Most recent event Tooltip | 28.10.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states The U.S.A. as represented by the Secretary, Department of Health and Human Services National Institues of Health Office of Technology Transfer 6011 Executive Boulevard, Suite 325 MSC 7660 Bethesda, MD 20852-7660 / US | [2022/41] | Inventor(s) | 01 /
ZHANG, Baoshan Bethesda, MD 20892 / US | 02 /
JOYCE, Michael Gordon Bethesda, MD 20892 / US | 03 /
CHENG, Cheng Bethesda, MD 20892 / US | 04 /
KONG, Rui Bethesda, MD 20892 / US | 05 /
XU, Kai Bethesda, MD 20892 / US | 06 /
KWONG, Peter Bethesda, MD 20892 / US | 07 /
MASCOLA, John Bethesda, MD 20892 / US | 08 /
ZHOU, Tongqing Bethesda, MD 20892 / US | 09 /
OU, Li Bethesda, MD 20892 / US | 10 /
KONG, Wing-Pui Bethesda, MD 20892 / US | 11 /
CHUANG, Gwo-Yu Bethesda, MD 20892 / US | 12 /
YANG, Yongping Bethesda, MD 20892 / US | 13 /
LIU, Kevin Bethesda, MD 20814 / US | [2022/41] | Representative(s) | Forresters IP LLP Skygarden Erika-Mann-Straße 11 80636 München / DE | [2022/41] | Application number, filing date | 22150234.7 | 03.10.2017 | [2022/41] | Priority number, date | US201662403266P | 03.10.2016 Original published format: US 201662403266 P | [2022/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4070815 | Date: | 12.10.2022 | Language: | EN | [2022/41] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.09.2022 | Classification | IPC: | A61K39/21, A61K39/385, C07K16/10, // A61K39/00 | [2022/41] | CPC: |
C07K16/1063 (EP);
A61K39/21 (US);
A61K39/12 (EP);
A61K39/385 (EP);
A61K47/6415 (US);
A61K47/643 (US);
A61K47/646 (US);
A61P31/18 (US);
C07K14/005 (US);
C12N7/00 (US);
A61K2039/545 (EP,US);
A61K2039/6037 (EP,US);
A61K2039/6081 (EP,US);
C07K2319/40 (US);
C07K2319/55 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/20] |
| Former [2022/41] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | HIV-1-ENV-FUSIONSPEPTID-IMMUNOGENE UND DEREN VERWENDUNG | [2022/41] | English: | HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE | [2022/41] | French: | IMMUNOGÈNES DE PEPTIDES DE FUSION ENV DU VIH-1 ET LEUR UTILISATION | [2022/41] | Examination procedure | 12.04.2023 | Amendment by applicant (claims and/or description) | 12.04.2023 | Examination requested [2023/20] | 12.04.2023 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP17784795.1 / EP3518968 | Fees paid | Renewal fee | 04.01.2022 | Renewal fee patent year 03 | 04.01.2022 | Renewal fee patent year 04 | 04.01.2022 | Renewal fee patent year 05 | 27.10.2022 | Renewal fee patent year 06 | 27.10.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO9315750 (HAYNES BARTON F [US]) [Y] 1-15 * claims 1, 7, 8-15 *; | [Y]WO0040616 (WILD CARL T [US], et al) [Y] 1-15 * claims 1-5 *; | [Y]WO2006077601 (YEDA RES & DEV [IL], et al) [Y] 1-15 * claims 1, 7; p19, §1-§2; *; | [A]WO2012055985 (ESTEVE LABOR DR [ES], et al) [A] 1-15* the whole document *; | [Y]WO2014093702 (USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES [US]) [Y] 1-15 * p 35, l 10 *; | [Y] - RUI KONG, "Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody", SCIENCE, (20160512), vol. 352, no. 6287, doi:10.1126/science.aaa7185, ISSN 0036-8075, pages 828 - 833, XP055427479 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1126/science.aaa7185 | [Y] - R. KONG ET AL, "Supplementary Materials for: Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody", SCIENCE, (20160513), vol. 352, no. 6287, doi:10.1126/science.aae0474, ISSN 0036-8075, pages 1 - 45, XP055427446 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1126/science.aae0474 | by applicant | US4428931 | US4488991 | US4547367 | US4547368 | US4709017 | US4722848 | US4997915 | US5091309 | US5151023 | US5217879 | WO9428152 | WO9502697 | WO9516772 | WO9534671 | WO9622378 | US5589466 | US5593972 | US5601826 | US5602095 | WO9712986 | WO9721826 | US5643578 | US5817317 | US5817637 | US5837511 | US5851806 | US5880103 | US5994106 | US6013264 | US6127175 | US6146902 | US6399076 | US6403094 | US6482616 | WO03002231 | US6696065 | US7195896 | - PERUZZI et al., Vaccine, (20090000), vol. 27, pages 1293 - 1300 | - SUTTER et al., Nature Struct, and Mol. Biol., (20080000), vol. 15, pages 939 - 947 | - WEGMANN, Clin Vaccine Immunol, (20150000), vol. 22, no. 9, pages 1004 - 1012 | - WU et al., Science, (20100000), vol. 329, pages 856 - 861 | - BAKER et al., Biophys. J., (19910000), vol. 60, pages 1445 - 1456 | - BITTER et al., Methods in Enzymology, (19870000), vol. 153, pages 516 - 544 | - DORIA-ROSE et al., Nature, (20140000), vol. 509, pages 455 - 461 | - "GENBANK(R", Database accession no. 1906382 | - H. HERWEIJER et al., Human Gene Therapy, (19950000), vol. 6, pages 1161 - 1167 | - ZHANG et al., Int. J. Mol. Sci., (20110000), vol. 12, pages 5406 - 5421 | - MOUGOUS et al., Science, (20060000), vol. 312, pages 1526 - 1530 | - ZHANG et al., J Mol. Biol., (20010000), vol. 306, pages 1099 - 1114 | - IZARD et al., PNAS, (19990000), vol. 96, pages 1240 - 1245 | - SMITHWATERMAN, Adv. Appl. Math., (19810000), vol. 2, page 482 | - NEEDLEMANWUNSCH, J. Mol. Biol., (19700000), vol. 48, page 443 | - PEARSONLIPMAN, Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, page 2444 | - HIGGINSSHARP, Gene, (19880000), vol. 73, pages 237 - 44 | - HIGGINSSHARP, CABIOS, (19890000), vol. 5, pages 151 - 3 | - CORPET et al., Nuc. Acids Res., (19880000), vol. 16, pages 10881 - 90 | - HUANG et al., Computer Appls. in the Biosciences, (19920000), vol. 8, pages 155 - 65 | - PEARSON et al., Meth. Mol. Bio., (19940000), vol. 24, pages 307 - 31 | - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 10 | - HAGENSEE et al., J. Virol., (19940000), vol. 68, pages 4503 - 4505 | - SCHNEIDER-OHRUMROSS, Curr. Top. Microbiol. Immunol., (20120000), vol. 354, page 53073 | - KONG et al., Science, (20160000), vol. 352, pages 828 - 833 | - MCALINDEN et al., J Biol Chem, (20030000), vol. 278, pages 42200 - 42207 | - HOPPE et al., FEBS Lett, (19940000), vol. 344, pages 191 - 195 | - FATTOM et al., Infect. Immun., (19900000), vol. 58, pages 2309 - 12 | - DEVI et al., PNAS, (19910000), vol. 88, pages 7175 - 79 | - SZU et al., Infect. Immun., (19910000), vol. 59, pages 4555 - 61 | - SZU et al., J Exp. Med., (19870000), vol. 166, pages 1510 - 24 | - PAVLIAKOVA et al., Infect. Immun., (20000000), vol. 68, pages 2161 - 66 | - ANDERSON et al., J. Immunol., (19860000), vol. 137, pages 1181 - 86 | - JENNINGSLUGOWSKI, J. Immunol., (19810000), vol. 127, pages 1011 - 18 | - KANEKIYO et al., Nature, (20130000), vol. 499, pages 102 - 106 | - KWON et al., Nat. Struct. Biol., (20150000), vol. 22, no. 7, pages 522 - 531 | - SANDERS et al., Plos Pathogens, (20130000), vol. 9, page el003618 | - SARZOTTI-KELSOE et al., J Immunol Methods, (20140000), vol. 409, pages 131 - 146 | - GEORGIEV et al., Science, (20130000), vol. 340, pages 751 - 756 | - HARBURY et al., Science, (19930000), vol. 262, pages 1401 - 1407 | - MIROSHNIKOV et al., Protein Eng, (19980000), vol. 11, pages 329 - 414 | - TAO et al., Structure, (19970000), vol. 5, pages 789 - 798 | - PEJCHAL et al., Science, (20110000), vol. 334, pages 1097 - 1103 | - BAROUCH et al., J. Virol, (20050000), vol. 79, pages 8828 - 8834 | - MADZAK et al., J. Gen. Virol., (19920000), vol. 73, page 15331536 | - BERKNER, Cur. Top. Microbiol. Immunol.,, (19920000), vol. 158, pages 39 - 6 | - BERLINER et al., Bio Techniques, (19880000), vol. 6, pages 616 - 629 | - BUCHSCHALCHER et al., J. Virol., (19920000), vol. 66, pages 29522965 - 2739 | - I. FROLOV et al., Proc. Natl. Acad. Sci. USA, vol. 93, pages 11371 - 11377 | - ROSENFELD et al., Cell, (19920000), vol. 68, pages 143 - 155 | - WILKINSON et al., Nucl. Acids Res., (19920000), vol. 20, pages 2233 - 2239 | - STRATFORD-PERRICAUDET et al., Hum. Gene Ther., (19900000), vol. 1, pages 241 - 256 | - MACKETT et al., Biotechnology, (19920000), vol. 24, pages 495 - 499 | - MARGOLSKEE, Curr. Top. Microbiol. Immunol., (19920000), vol. 158, pages 67 - 123 | - ON et al., Gene, (19900000), vol. 89, pages 279 - 282 | - FINK et al., Hum. Gene Ther., (19920000), vol. 3, pages 11 - 19 | - BREAKFIELD et al., Mol. Neurobiol., (19870000), vol. 1, pages 337 - 371 | - FRESSE et al., Biochem. Pharmacol., (19900000), vol. 40, pages 2189 - 2199 | - S. SCHLESINGER, Trends Biotechnol, (19930000), vol. 11, pages 18 - 22 | - BRANDYOPADHYAY et al., Mol. Cell Biol., (19840000), vol. 4, pages 1730 - 1737 | - MILLER et al., Mol. Cell Biol., (19850000), vol. 5, pages 431 - 437 | - MANN et al., J. Virol., (19850000), vol. 54, pages 401 - 407 | - PAGE et al., J. Virol., (19900000), vol. 64, pages 5370 - 5276 | - NOTKA et al., Biol. Chem., (19990000), vol. 380, pages 341 - 52 | - GOLDMANN et al., J. Virol., (19990000), vol. 73, pages 4465 - 9 | - JIANG et al., Vaccine, (19990000), vol. 17, pages 1005 - 13 | - CASAL, Biotechnology and Applied Biochemistry, (19990000), vol. 29, pages 141 - 150 | - HURTADO et al., J. Virol., (19960000), vol. 70, pages 5422 - 9 | - LI et al., J. Virol., (19970000), vol. 71, pages 7207 - 13 | - NEWMAN et al., Critical Reviews in Therapeutic Drug Carrier Systems, (19980000), vol. 15, pages 89 - 142 | - ARCHIN et al., AIDS, (20080000), vol. 22, pages 1131 - 1135 | - MARTIN, Nature Biotechnology, (20030000), vol. 21, pages 71 - 76 | - MASCOLA et al., J. Virol., (20050000), vol. 79, pages 10103 - 10107 | - MOWATDONACHIE, Immunol. Today, (19910000), vol. 12, page 383 | - TAKAHASHI et al., Nature, (19900000), vol. 344, page 873 | - STOVER, Nature, (19910000), vol. 351, pages 456 - 460 | - WALKER et al., Science, (20090000), vol. 326, pages 1123 - 1127 | - GORMAN et al., Nat Struct Mol Biol, (20160000), vol. 23, pages 81 - 90 | - MCLELLAN et al., Nature, (20110000), vol. 477, pages 466 - 470 | - ANDRABI et al., Immunity, (20150000), vol. 43, pages 1053 - 1063 | - BRINEY et al., PLoS One, (20120000), vol. 7, page e36750 | - KONG et al., Nat Struct Mol Biol, (20130000), vol. 20, pages 796 - 803 | - HUANG et al., Nature, (20120000), vol. 491, pages 406 - 412 | - MUSTER et al., J Virol, (19940000), vol. 68, pages 4031 - 4034 | - MUSTER et al., J Virol, (19930000), vol. 67, pages 6642 - 6647 | - STIEGLER et al., AIDS Res Hum Retroviruses, (20010000), vol. 17, pages 1757 - 1765 | - IRIMIA et al., Immunity, (20160000), vol. 44, pages 21 - 31 | - SEAMAN et al., J Virol, (20100000), vol. 84, pages 1439 - 1452 | - OFEK et al., J Virol, (20040000), vol. 78, pages 10724 - 10737 | - HAYNES et al., Hum Antibodies, (20050000), vol. 14, pages 59 - 67 | - CARRKIM, Cell, (19930000), vol. 73, pages 823 - 832 | - BOUDKO et al., J Mol. Biol., (20090000), vol. 392, pages 787 - 802 | - TAN et al., J cell biol, (20020000), vol. 159, pages 373 - 382 | - CHU et al., J Mol. Biol., (20020000), vol. 323, pages 253 - 262 | - SANDERS et al., PLoS pathogens, (20130000), vol. 9, page el003618 | - KWON et al., Nat Struct Mol Biol, (20150000), vol. 22, pages 522 - 531 | - TRKOLA, Nat Med, (20050000), vol. 11, pages 615 - 622 | - TRKOLA et al., J Virol, (20080000), vol. 82, pages 1591 - 1599 | - TRKOLA et al., J Virol, (19960000), vol. 70, pages 1100 - 1108 | - CHU et al., "Redesign of a four-helix bundle protein by phage display coupled with proteolysis and structural characterization by NMR and x-ray crystallography", J. Mol. Biol., (20020000), vol. 323, doi:10.1016/S0022-2836(02)00884-7, pages 253 - 262, XP004449868 DOI: http://dx.doi.org/10.1016/S0022-2836(02)00884-7 | - PANCERA et al., PLOS ONE, (20130000), vol. 8, page e55701 | - HERMANSON, Bioconjugation Techniques, Academic Press, pages 306 - 308 | WO2015US48729 |